SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : wla(warner lambert)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sonki who wrote (548)2/19/1999 10:04:00 PM
From: Anthony Wong  Read Replies (1) of 942
 
Smith Barney put out a piece regarding the new insulin sensitizers such as Eli Lilly's (LLY) Actos and SmithKline Beecham's (SBH) Avandia. This is probably the reason why Warner-Lambert (WLA) was weak today as these new products pose a threat to WLA's Rezulin.

From labpuppy.com
labpuppy.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News